| Histone deacetylase inhibitor panobinostat induces clinical responses with associated alterations in gene expression profiles in cutaneous T-cell lymphoma L Ellis, Y Pan, GK Smyth, DJ George, C McCormack, R Williams-Truax, ... Clinical Cancer Research 14 (14), 4500-4510, 2008 | 345 | 2008 |
| Differences in age and body site distribution of the histological subtypes of basal cell carcinoma: a possible indicator of differing causes CJ McCormack, JW Kelly, AP Dorevitch Archives of dermatology 133 (5), 593-596, 1997 | 341 | 1997 |
| Lack of durable disease control with chemotherapy for mycosis fungoides and Sézary syndrome: a comparative study of systemic therapy CFM Hughes, A Khot, C McCormack, S Lade, DA Westerman, R Twigger, ... Blood, The Journal of the American Society of Hematology 125 (1), 71-81, 2015 | 234 | 2015 |
| Analysis of dermatologic events in vemurafenib‐treated patients with melanoma ME Lacouture, M Duvic, A Hauschild, VG Prieto, C Robert, D Schadendorf, ... The oncologist 18 (3), 314-322, 2013 | 227 | 2013 |
| Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation SO Arulogun, HM Prince, J Ng, S Lade, GF Ryan, O Blewitt, C McCormack Blood, The Journal of the American Society of Hematology 112 (8), 3082-3087, 2008 | 208 | 2008 |
| Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome T Gayden, FE Sepulveda, DA Khuong-Quang, J Pratt, ET Valera, ... Nature genetics 50 (12), 1650-1657, 2018 | 185 | 2018 |
| Treatment of patients with advanced mycosis fungoides and Sezary syndrome with alemtuzumab GA Kennedy, JF Seymour, M Wolf, H Januszewicz, J Davison, ... European journal of haematology 71 (4), 250-256, 2003 | 172 | 2003 |
| The use of methotrexate in dermatology: a review S Shen, T O’Brien, LM Yap, HM Prince, CJ McCormack Australasian Journal of Dermatology 53 (1), 1-18, 2012 | 151 | 2012 |
| Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium P Quaglino, M Maule, HM Prince, P Porcu, S Horwitz, M Duvic, R Talpur, ... Annals of Oncology 28 (10), 2517-2525, 2017 | 138 | 2017 |
| Rituximab for the treatment of the skin manifestations of dermatomyositis: a report of 3 cases HV Dinh, C McCormack, S Hall, HM Prince Journal of the American Academy of Dermatology 56 (1), 148-153, 2007 | 116 | 2007 |
| Who removes pigmented skin lesions?: A study of the ratio of melanoma to other benign pigmented tumors removed by different categories of physicians in Australia in 1989 and 1994 R Marks, D Jolley, C McCormack, AP Dorevitch Journal of the American Academy of Dermatology 36 (5), 721-726, 1997 | 90 | 1997 |
| Rituximab in the adjuvant treatment of pemphigus vulgaris: a prospective open‐label pilot study in five patients MSY Goh, C McCormack, HV Dinh, B Welsh, P Foley, HM Prince British Journal of Dermatology 156 (5), 990-996, 2007 | 87 | 2007 |
| Graft-versus-lymphoma effect in refractory cutaneous T-cell lymphoma after reduced-intensity HLA-matched sibling allogeneic stem cell transplantation KE Herbert, A Spencer, A Grigg, G Ryan, C McCormack, HM Prince Bone marrow transplantation 34 (6), 521-525, 2004 | 81 | 2004 |
| Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five cases AP Ng, S Lade, T Rutherford, C McCormack, HM Prince, DA Westerman Haematologica 91 (1), 143-144, 2006 | 72 | 2006 |
| Surveillance imaging with FDG-PET/CT in the post-operative follow-up of stage 3 melanoma J Lewin, L Sayers, D Kee, I Walpole, A Sanelli, L Te Marvelde, ... Annals of Oncology 29 (7), 1569-1574, 2018 | 58 | 2018 |
| Systemic treatment options for advanced-stage mycosis fungoides and Sézary syndrome L Photiou, C van der Weyden, C McCormack, H Miles Prince Current oncology reports 20, 1-14, 2018 | 56 | 2018 |
| Time to next treatment as a meaningful endpoint for trials of primary cutaneous lymphoma BA Campbell, JJ Scarisbrick, YH Kim, RA Wilcox, C McCormack, ... Cancers 12 (8), 2311, 2020 | 51 | 2020 |
| Extracorporeal photopheresis for the treatment of Sezary syndrome using a novel treatment protocol S Arulogun, HM Prince, P Gambell, S Lade, G Ryan, E Eaton, ... Journal of the American Academy of Dermatology 59 (4), 589-595, 2008 | 47 | 2008 |
| Refractory subacute cutaneous lupus erythematosus successfully treated with rituximab V Kieu, T O'Brien, LM Yap, C Baker, P Foley, G Mason, HM Prince, ... Australasian journal of dermatology 50 (3), 202-206, 2009 | 42 | 2009 |
| Mycosis fungoides and S ézary syndrome: Current challenges in assessment, management and prognostic markers CFM Hughes, K Newland, C McCormack, S Lade, HM Prince Australasian Journal of Dermatology 57 (3), 182-191, 2016 | 41 | 2016 |
HM Prince在 petermac.org 的电子邮件经过验证
